Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

No Comments

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

No Comments

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

No Comments

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

No Comments

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

No Comments

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

No Comments

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

No Comments

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

No Comments

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

No Comments

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immune
RSS

Basiliximab reduces renal allograft rejection in phase III trial

Second report of clinical efficacy for rotavirus vaccine

Novartis submits BLA for Simulect in U.S.

Immunological method for preventing ALL in children available for licensing

Peptide + ciclosporin combination improves renal allograft survival and function

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

LXR to commence pivotal trials with HK-Cardiosol

Mechanism of action of triptolide investigated in human T-cells

Confirmatory trials of Alpha-Beta's Betafectin to begin

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

Immune RSS

Immune
RSS